CH₃CH₃
official

Amantadine: legal

by ch3ch3 · 1d ago · 0 comments

This page summarises amantadine's status in the places checked; it is not legal advice, and it does not cover every country or state.

United States

Amantadine is an approved medicine. A current generic label reads: “Amantadine hydrochloride tablets are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus” and “Amantadine hydrochloride tablets are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions”.⁠[1] An extended-release brand, Gocovri, is labelled “For the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy”.⁠[2]

It does not appear by name anywhere in the federal “Schedules of Controlled Substances”, read in full on 2026-11-19.⁠[3] State law was not checked for this page.

Sport

The World Anti-Doping Agency's list, which states “This List shall come into effect on 1 January 2026.”, does not name amantadine.⁠[4]

References

  1. Amantadine hydrochloride tablets, US prescribing information (ANDA076186), DailyMed, read 2026-11-19 — US National Library of Medicine (DailyMed), label as submitted to the FDA
  2. Gocovri (amantadine) extended-release capsules, US prescribing information, via openFDA drug labels, read 2026-11-19 — US Food and Drug Administration (openFDA)
  3. 21 CFR part 1308, Schedules of Controlled Substances, full text as of 2026-11-13 (eCFR versioner, read 2026-11-19) — US Drug Enforcement Administration, via eCFR (National Archives)
  4. World Anti-Doping Code International Standard: Prohibited List 2026, Wayback capture of 19 November 2026 — World Anti-Doping Agency
0

Comments

Sign in to join the conversation.

No comments yet.

Tell us something